Description
BTA-9881, also known as AZD-9639 and MEDI-564, is a viral fusion protein inhibitor potentially for the treatment of respiratory syncytial virus infection.
Product information
CAS Number: 1646857-24-0
Molecular Weight: 390.82
Formula: C21H15ClN4O2
Chemical Name: (S)-9b-(4-chlorophenyl)-1-nicotinoyl-1, 2, 3, 9b-tetrahydro-5H-imidazo[1', 2':1, 2]pyrrolo[3, 4-c]pyridin-5-one
Smiles: O=C(C1=CN=CC=C1)N1CCN2C(=O)C3=CC=NC=C3[C@@]21C1C=CC(Cl)=CC=1
InChiKey: QZSZPSDRJPPZDZ-OAQYLSRUSA-N
InChi: InChI=1S/C21H15ClN4O2/c22-16-5-3-15(4-6-16)21-18-13-24-9-7-17(18)20(28)26(21)11-10-25(21)19(27)14-2-1-8-23-12-14/h1-9,12-13H,10-11H2/t21-/m1/s1
Technical Data
Appearance: Solid Power
Purity: ≥98% (or refer to the Certificate of Analysis)
Solubility: To be determined
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.
Shelf Life: ≥12 months if stored properly.
Stock Solution Storage: 0 - 4 oC for 1 month or refer to the Certificate of Analysis.
Drug Formulation: To be determined
HS Tariff Code: 382200
References:
- Bonfanti JF, Roymans D. Prospects for the development of fusion inhibitors to treat human respiratory syncytial virus infection. Curr Opin Drug Discov Devel. 2009 Jul;12(4):479-87. Review. PubMed PMID: 19562644.
Products are for research use only. Not for human use.
Payment & Security
Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.